Stocks
Novo Nordisk (NVO) Debt/EBITDA US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 0.03 | 0.03 | -0.03 | 0.52 | 0.66 | 0.69 | ||
| Changes by years, y/y, % | -79% | -6% | -206% | -1 911% | +28% | |||
Novo Nordisk. Debt/EBITDA
Novo Nordisk. Debt/EBITDA, changes, %
Novo Nordisk (NVO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.47 | 0.46 | 0.41 | 0.66 | 0.69 | 0.69 | ||
| Changes by years, y/y, % | +227% | -1 188% | -393% | +34% | +47% | |||
| Changes by quarters, q/q, % | -5% | -1% | -12% | +60% | +5% | |||
